Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016)

Jazz Pharmaceuticals (JAZZ) posted quarterly Construction in Progress of $66.2 million for Q1 2016, up 33.85% year-over-year from $49.4 million in Q2 2015, and up 5.04% quarter-over-quarter from $63.0 million in Q4 2015.

Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016) Analysis & Trends

Jazz Pharmaceuticals' Construction in Progress history runs 7 years deep, the most recent figure standing at $66.2 million for Q1 2016.

  • In Q1 2016, Construction in Progress rose 33.85% year-over-year to $66.2 million; the TTM figure through Mar 2016 stood at $66.2 million (up 33.85% YoY), while the FY2015 annual figure was $63.0 million, up 69.63% from the prior year.
  • Construction in Progress for Q1 2016 stood at $66.2 million, up from $63.0 million in the prior quarter.
  • The five-year high for Construction in Progress was $66.2 million in Q1 2016, with the low at $148000.0 in Q1 2012.
  • The 5-year median for Construction in Progress is $10.6 million (2014), against an average of $24.0 million.
  • The sharpest annual moves came in 2013 and 2016: Construction in Progress soared 1239.19% in 2013, then soared 33.85% in 2016.
  • Jazz Pharmaceuticals' Construction in Progress stood at $1.1 million in 2012, then jumped by 286.61% to $4.4 million in 2013, then jumped by 746.51% to $37.1 million in 2014, then soared by 69.63% to $63.0 million in 2015, then rose by 5.04% to $66.2 million in 2016.
  • Business Quant data shows JAZZ's Construction in Progress at $66.2 million in Q1 2016, $63.0 million in Q4 2015, and $61.1 million in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 152.67 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Jazz Pharmaceuticals 15.90 Bn 14.28 Bn 1.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2016 66.19 Mn
Dec 31, 2015 63.01 Mn
Sep 30, 2015 61.06 Mn
Jun 30, 2015 57.88 Mn
Mar 31, 2015 49.45 Mn
Dec 31, 2014 37.15 Mn
Sep 30, 2014 24.25 Mn
Jun 30, 2014 18.04 Mn
Mar 31, 2014 10.64 Mn
Dec 31, 2013 4.39 Mn
Sep 30, 2013 5.06 Mn
Jun 30, 2013 4.20 Mn
Mar 31, 2013 1.98 Mn
Dec 31, 2012 1.14 Mn
Sep 30, 2012 1.05 Mn
Jun 30, 2012 2.46 Mn
Mar 31, 2012 148,000.00
Dec 31, 2011 689,000.00
Dec 31, 2010 73,000.00